Seaweed power: can Blue-Green algae shield cancer patients from Chemo's agony?
NCT ID NCT05025826
Summary
This study is testing whether a highly concentrated extract from blue-green algae (spirulina), called Phycocare®, can protect against nerve damage caused by a chemotherapy drug called oxaliplatin. The trial involves 110 adults with advanced stomach, intestinal, or pancreatic cancers who are starting this specific chemo. Participants will take either the spirulina extract or a placebo (a dummy pill) during and for three months after their chemotherapy to see if it reduces nerve pain and improves quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC GASTRIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Hospitalier de Cholet
Cholet, 49300, France
-
Chd La Roche Sur Yon
La Roche-sur-Yon, France
-
Clermont-Ferrand UH
Clermont-Ferrand, France, France
-
Foch Suresnes Hosptial
Suresnes, France
-
Hôpital le Confluent
Nantes, 44000, France
-
Mutaliste Clinic Saint Nazaire
Saint-Nazaire, France
-
Nantes Uh
Nantes, France
-
Saint Gregoire Clinique
Rennes, France
Conditions
Explore the condition pages connected to this study.